 | • レポートコード：MRC2012B0452 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、医療用ナノテクノロジーの世界市場を広く調査・分析し、今後の市場展望をまとめております。医療用ナノテクノロジーの種類別市場規模（ナノメディシン、ナノ医療機器、ナノ診断、その他）、用途別市場規模（抗がん剤、CNS製品、抗感染症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Amgen、Merck & Co、UCB、Teva Pharmaceuticals、Sanofi、Abbott、Stryker、Celgene、Roche、Biogen、Smith & Nephew、Shire、Gilead Sciences、Endo International、Leadiant Biosciences、Johnson & Johnson、Pfizer、Ipsen、Kyowa Hakko Kirin、3M Company、 ・地域別グローバル市場分析 2015年-2020年 ・医療用ナノテクノロジーの北米市場（アメリカ、カナダ、メキシコ） ・医療用ナノテクノロジーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・医療用ナノテクノロジーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・医療用ナノテクノロジーの南米市場（ブラジル、アルゼンチン） ・医療用ナノテクノロジーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ナノメディシン、ナノ医療機器、ナノ診断、その他 ・用途別分析：抗がん剤、CNS製品、抗感染症、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Healthcare Nanotechnology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Healthcare Nanotechnology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.1%% in the forecast period of 2020 to 2025 and will expected to reach USD 257080 million by 2025, from USD 181190 million in 2019.
Market segmentation
Healthcare Nanotechnology market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Healthcare Nanotechnology market has been segmented into:
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Others
By Application, Healthcare Nanotechnology has been segmented into:
Anticancer
CNS Product
Anti-infective
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Healthcare Nanotechnology market presented in the report. This section sheds light on the sales growth of different regional and country-level Healthcare Nanotechnology markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Healthcare Nanotechnology market.
The report offers in-depth assessment of the growth and other aspects of the Healthcare Nanotechnology market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Healthcare Nanotechnology Market Share Analysis
Healthcare Nanotechnology competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Healthcare Nanotechnology sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Healthcare Nanotechnology sales, revenue and market share for each player covered in this report.
The major players covered in Healthcare Nanotechnology are:
Amgen
Merck & Co
UCB
Teva Pharmaceuticals
Sanofi
Abbott
Stryker
Celgene
Roche
Biogen
Smith & Nephew
Shire
Gilead Sciences
Endo International
Leadiant Biosciences
Johnson & Johnson
Pfizer
Ipsen
Kyowa Hakko Kirin
3M Company
Among other players domestic and global, Healthcare Nanotechnology market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Healthcare Nanotechnology Market Overview
1.1 Product Overview and Scope of Healthcare Nanotechnology
1.2 Classification of Healthcare Nanotechnology by Type
1.2.1 Global Healthcare Nanotechnology Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Healthcare Nanotechnology Revenue Market Share by Type in 2019
1.2.3 Nanomedicine
1.2.4 Nano Medical Devices
1.2.5 Nano Diagnosis
1.2.6 Others
1.3 Global Healthcare Nanotechnology Market by Application
1.3.1 Overview: Global Healthcare Nanotechnology Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Anticancer
1.3.3 CNS Product
1.3.4 Anti-infective
1.3.5 Others
1.4 Global Healthcare Nanotechnology Market by Regions
1.4.1 Global Healthcare Nanotechnology Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Healthcare Nanotechnology (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Healthcare Nanotechnology Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Healthcare Nanotechnology Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Healthcare Nanotechnology Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Healthcare Nanotechnology Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Healthcare Nanotechnology Status and Prospect (2015-2025)
2 Company Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen SWOT Analysis
2.1.4 Amgen Product and Services
2.1.5 Amgen Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck & Co
2.2.1 Merck & Co Details
2.2.2 Merck & Co Major Business
2.2.3 Merck & Co SWOT Analysis
2.2.4 Merck & Co Product and Services
2.2.5 Merck & Co Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2018-2019)
2.3 UCB
2.3.1 UCB Details
2.3.2 UCB Major Business
2.3.3 UCB SWOT Analysis
2.3.4 UCB Product and Services
2.3.5 UCB Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2018-2019)
2.4 Teva Pharmaceuticals
2.4.1 Teva Pharmaceuticals Details
2.4.2 Teva Pharmaceuticals Major Business
2.4.3 Teva Pharmaceuticals SWOT Analysis
2.4.4 Teva Pharmaceuticals Product and Services
2.4.5 Teva Pharmaceuticals Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2018-2019)
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business
2.6.3 Abbott Product and Services
2.6.4 Abbott Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2018-2019)
2.7 Stryker
2.7.1 Stryker Details
2.7.2 Stryker Major Business
2.7.3 Stryker Product and Services
2.7.4 Stryker Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2018-2019)
2.8 Celgene
2.8.1 Celgene Details
2.8.2 Celgene Major Business
2.8.3 Celgene Product and Services
2.8.4 Celgene Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2018-2019)
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business
2.9.3 Roche Product and Services
2.9.4 Roche Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2018-2019)
2.10 Biogen
2.10.1 Biogen Details
2.10.2 Biogen Major Business
2.10.3 Biogen Product and Services
2.10.4 Biogen Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2018-2019)
2.11 Smith & Nephew
2.11.1 Smith & Nephew Details
2.11.2 Smith & Nephew Major Business
2.11.3 Smith & Nephew Product and Services
2.11.4 Smith & Nephew Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2018-2019)
2.12 Shire
2.12.1 Shire Details
2.12.2 Shire Major Business
2.12.3 Shire Product and Services
2.12.4 Shire Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2018-2019)
2.13 Gilead Sciences
2.13.1 Gilead Sciences Details
2.13.2 Gilead Sciences Major Business
2.13.3 Gilead Sciences Product and Services
2.13.4 Gilead Sciences Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2018-2019)
2.14 Endo International
2.14.1 Endo International Details
2.14.2 Endo International Major Business
2.14.3 Endo International Product and Services
2.14.4 Endo International Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2018-2019)
2.15 Leadiant Biosciences
2.15.1 Leadiant Biosciences Details
2.15.2 Leadiant Biosciences Major Business
2.15.3 Leadiant Biosciences Product and Services
2.15.4 Leadiant Biosciences Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2018-2019)
2.16 Johnson & Johnson
2.16.1 Johnson & Johnson Details
2.16.2 Johnson & Johnson Major Business
2.16.3 Johnson & Johnson Product and Services
2.16.4 Johnson & Johnson Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2018-2019)
2.17 Pfizer
2.17.1 Pfizer Details
2.17.2 Pfizer Major Business
2.17.3 Pfizer Product and Services
2.17.4 Pfizer Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2018-2019)
2.18 Ipsen
2.18.1 Ipsen Details
2.18.2 Ipsen Major Business
2.18.3 Ipsen Product and Services
2.18.3 Ipsen Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2018-2019)
2.19 Kyowa Hakko Kirin
2.19.1 Kyowa Hakko Kirin Details
2.19.2 Kyowa Hakko Kirin Major Business
2.19.3 Kyowa Hakko Kirin Product and Services
2.19.4 Kyowa Hakko Kirin Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2018-2019)
2.20 3M Company
2.20.1 3M Company Details
2.20.2 3M Company Major Business
2.20.3 3M Company Product and Services
2.20.4 3M Company Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Healthcare Nanotechnology Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Healthcare Nanotechnology Players Market Share
3.2.2 Top 10 Healthcare Nanotechnology Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Healthcare Nanotechnology Revenue and Market Share by Regions
4.2 North America Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
4.3 Europe Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
4.5 South America Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
5 North America Healthcare Nanotechnology Revenue by Countries
5.1 North America Healthcare Nanotechnology Revenue by Countries (2015-2020)
5.2 USA Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
5.3 Canada Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
5.4 Mexico Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
6 Europe Healthcare Nanotechnology Revenue by Countries
6.1 Europe Healthcare Nanotechnology Revenue by Countries (2015-2020)
6.2 Germany Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
6.3 UK Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
6.4 France Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
6.5 Russia Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
6.6 Italy Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Healthcare Nanotechnology Revenue by Countries
7.1 Asia-Pacific Healthcare Nanotechnology Revenue by Countries (2015-2020)
7.2 China Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
7.3 Japan Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
7.4 Korea Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
7.5 India Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
8 South America Healthcare Nanotechnology Revenue by Countries
8.1 South America Healthcare Nanotechnology Revenue by Countries (2015-2020)
8.2 Brazil Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
8.3 Argentina Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Healthcare Nanotechnology by Countries
9.1 Middle East & Africa Healthcare Nanotechnology Revenue by Countries (2015-2020)
9.2 Saudi Arabia Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
9.3 UAE Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
9.4 Egypt Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
9.5 South Africa Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Healthcare Nanotechnology Revenue and Market Share by Type (2015-2020)
10.2 Global Healthcare Nanotechnology Market Forecast by Type (2019-2024)
10.3 Nanomedicine Revenue Growth Rate (2015-2025)
10.4 Nano Medical Devices Revenue Growth Rate (2015-2025)
10.5 Nano Diagnosis Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Healthcare Nanotechnology Market Segment by Application
11.1 Global Healthcare Nanotechnology Revenue Market Share by Application (2015-2020)
11.2 Healthcare Nanotechnology Market Forecast by Application (2019-2024)
11.3 Anticancer Revenue Growth (2015-2020)
11.4 CNS Product Revenue Growth (2015-2020)
11.5 Anti-infective Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Healthcare Nanotechnology Market Size Forecast (2021-2025)
12.1 Global Healthcare Nanotechnology Market Size Forecast (2021-2025)
12.2 Global Healthcare Nanotechnology Market Forecast by Regions (2021-2025)
12.3 North America Healthcare Nanotechnology Revenue Market Forecast (2021-2025)
12.4 Europe Healthcare Nanotechnology Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Healthcare Nanotechnology Revenue Market Forecast (2021-2025)
12.6 South America Healthcare Nanotechnology Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Healthcare Nanotechnology Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Healthcare Nanotechnology Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Healthcare Nanotechnology by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Healthcare Nanotechnology Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Healthcare Nanotechnology Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Healthcare Nanotechnology Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Amgen Corporate Information, Location and Competitors
Table 7. Amgen Healthcare Nanotechnology Major Business
Table 8. Amgen Healthcare Nanotechnology Total Revenue (USD Million) (2017-2018)
Table 9. Amgen SWOT Analysis
Table 10. Amgen Healthcare Nanotechnology Product and Solutions
Table 11. Amgen Healthcare Nanotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Merck & Co Corporate Information, Location and Competitors
Table 13. Merck & Co Healthcare Nanotechnology Major Business
Table 14. Merck & Co Healthcare Nanotechnology Total Revenue (USD Million) (2018-2019)
Table 15. Merck & Co SWOT Analysis
Table 16. Merck & Co Healthcare Nanotechnology Product and Solutions
Table 17. Merck & Co Healthcare Nanotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. UCB Corporate Information, Location and Competitors
Table 19. UCB Healthcare Nanotechnology Major Business
Table 20. UCB Healthcare Nanotechnology Total Revenue (USD Million) (2017-2018)
Table 21. UCB SWOT Analysis
Table 22. UCB Healthcare Nanotechnology Product and Solutions
Table 23. UCB Healthcare Nanotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Teva Pharmaceuticals Corporate Information, Location and Competitors
Table 25. Teva Pharmaceuticals Healthcare Nanotechnology Major Business
Table 26. Teva Pharmaceuticals Healthcare Nanotechnology Total Revenue (USD Million) (2017-2018)
Table 27. Teva Pharmaceuticals SWOT Analysis
Table 28. Teva Pharmaceuticals Healthcare Nanotechnology Product and Solutions
Table 29. Teva Pharmaceuticals Healthcare Nanotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Sanofi Corporate Information, Location and Competitors
Table 31. Sanofi Healthcare Nanotechnology Major Business
Table 32. Sanofi Healthcare Nanotechnology Total Revenue (USD Million) (2017-2018)
Table 33. Sanofi SWOT Analysis
Table 34. Sanofi Healthcare Nanotechnology Product and Solutions
Table 35. Sanofi Healthcare Nanotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Abbott Corporate Information, Location and Competitors
Table 37. Abbott Healthcare Nanotechnology Major Business
Table 38. Abbott Healthcare Nanotechnology Total Revenue (USD Million) (2017-2018)
Table 39. Abbott SWOT Analysis
Table 40. Abbott Healthcare Nanotechnology Product and Solutions
Table 41. Abbott Healthcare Nanotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Stryker Corporate Information, Location and Competitors
Table 43. Stryker Healthcare Nanotechnology Major Business
Table 44. Stryker Healthcare Nanotechnology Total Revenue (USD Million) (2017-2018)
Table 45. Stryker SWOT Analysis
Table 46. Stryker Healthcare Nanotechnology Product and Solutions
Table 47. Stryker Healthcare Nanotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Celgene Corporate Information, Location and Competitors
Table 49. Celgene Healthcare Nanotechnology Major Business
Table 50. Celgene Healthcare Nanotechnology Total Revenue (USD Million) (2017-2018)
Table 51. Celgene SWOT Analysis
Table 52. Celgene Healthcare Nanotechnology Product and Solutions
Table 53. Celgene Healthcare Nanotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Roche Corporate Information, Location and Competitors
Table 55. Roche Healthcare Nanotechnology Major Business
Table 56. Roche Healthcare Nanotechnology Total Revenue (USD Million) (2017-2018)
Table 57. Roche SWOT Analysis
Table 58. Roche Healthcare Nanotechnology Product and Solutions
Table 59. Roche Healthcare Nanotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Biogen Corporate Information, Location and Competitors
Table 61. Biogen Healthcare Nanotechnology Major Business
Table 62. Biogen Healthcare Nanotechnology Total Revenue (USD Million) (2017-2018)
Table 63. Biogen SWOT Analysis
Table 64. Biogen Healthcare Nanotechnology Product and Solutions
Table 65. Biogen Healthcare Nanotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Smith & Nephew Corporate Information, Location and Competitors
Table 67. Smith & Nephew Healthcare Nanotechnology Major Business
Table 68. Smith & Nephew Healthcare Nanotechnology Total Revenue (USD Million) (2017-2018)
Table 69. Smith & Nephew SWOT Analysis
Table 70. Smith & Nephew Healthcare Nanotechnology Product and Solutions
Table 71. Smith & Nephew Healthcare Nanotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Shire Corporate Information, Location and Competitors
Table 73. Shire Healthcare Nanotechnology Major Business
Table 74. Shire Healthcare Nanotechnology Total Revenue (USD Million) (2017-2018)
Table 75. Shire SWOT Analysis
Table 76. Shire Healthcare Nanotechnology Product and Solutions
Table 77. Shire Healthcare Nanotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Gilead Sciences Corporate Information, Location and Competitors
Table 79. Gilead Sciences Healthcare Nanotechnology Major Business
Table 80. Gilead Sciences Healthcare Nanotechnology Total Revenue (USD Million) (2017-2018)
Table 81. Gilead Sciences SWOT Analysis
Table 82. Gilead Sciences Healthcare Nanotechnology Product and Solutions
Table 83. Gilead Sciences Healthcare Nanotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Endo International Corporate Information, Location and Competitors
Table 85. Endo International Healthcare Nanotechnology Major Business
Table 86. Endo International Healthcare Nanotechnology Total Revenue (USD Million) (2017-2018)
Table 87. Endo International SWOT Analysis
Table 88. Endo International Healthcare Nanotechnology Product and Solutions
Table 89. Endo International Healthcare Nanotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Leadiant Biosciences Corporate Information, Location and Competitors
Table 91. Leadiant Biosciences Healthcare Nanotechnology Major Business
Table 92. Leadiant Biosciences Healthcare Nanotechnology Total Revenue (USD Million) (2017-2018)
Table 93. Leadiant Biosciences SWOT Analysis
Table 94. Leadiant Biosciences Healthcare Nanotechnology Product and Solutions
Table 95. Leadiant Biosciences Healthcare Nanotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Johnson & Johnson Corporate Information, Location and Competitors
Table 97. Johnson & Johnson Healthcare Nanotechnology Major Business
Table 98. Johnson & Johnson Healthcare Nanotechnology Total Revenue (USD Million) (2017-2018)
Table 99. Johnson & Johnson SWOT Analysis
Table 100. Johnson & Johnson Healthcare Nanotechnology Product and Solutions
Table 101. Johnson & Johnson Healthcare Nanotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Pfizer Corporate Information, Location and Competitors
Table 103. Pfizer Healthcare Nanotechnology Major Business
Table 104. Pfizer Healthcare Nanotechnology Total Revenue (USD Million) (2017-2018)
Table 105. Pfizer SWOT Analysis
Table 106. Pfizer Healthcare Nanotechnology Product and Solutions
Table 107. Pfizer Healthcare Nanotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Ipsen Healthcare Nanotechnology Type and Application
Table 109. Ipsen Healthcare Nanotechnology Major Business
Table 110. Ipsen Healthcare Nanotechnology Total Revenue (USD Million) (2017-2018)
Table 111. Ipsen SWOT Analysis
Table 112. Ipsen Healthcare Nanotechnology Product and Solutions
Table 113. Ipsen Healthcare Nanotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. Kyowa Hakko Kirin Corporate Information, Location and Competitors
Table 115. Kyowa Hakko Kirin Healthcare Nanotechnology Major Business
Table 116. Kyowa Hakko Kirin Healthcare Nanotechnology Total Revenue (USD Million) (2017-2018)
Table 117. Kyowa Hakko Kirin SWOT Analysis
Table 118. Kyowa Hakko Kirin Healthcare Nanotechnology Product and Solutions
Table 119. Kyowa Hakko Kirin Healthcare Nanotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 120. 3M Company Corporate Information, Location and Competitors
Table 121. 3M Company Healthcare Nanotechnology Major Business
Table 122. 3M Company Healthcare Nanotechnology Total Revenue (USD Million) (2017-2018)
Table 123. 3M Company SWOT Analysis
Table 124. 3M Company Healthcare Nanotechnology Product and Solutions
Table 125. 3M Company Healthcare Nanotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 126. Global Healthcare Nanotechnology Revenue (Million USD) by Players (2015-2020)
Table 127. Global Healthcare Nanotechnology Revenue Share by Players (2015-2020)
Table 128. Global Healthcare Nanotechnology Revenue (Million USD) by Regions (2015-2020)
Table 129. Global Healthcare Nanotechnology Revenue Market Share by Regions (2015-2020)
Table 130. North America Healthcare Nanotechnology Revenue by Countries (2015-2020)
Table 131. North America Healthcare Nanotechnology Revenue Market Share by Countries (2015-2020)
Table 132. Europe Healthcare Nanotechnology Revenue (Million USD) by Countries (2015-2020)
Table 133. Asia-Pacific Healthcare Nanotechnology Revenue (Million USD) by Countries (2015-2020)
Table 134. South America Healthcare Nanotechnology Revenue by Countries (2015-2020)
Table 135. South America Healthcare Nanotechnology Revenue Market Share by Countries (2015-2020)
Table 136. Middle East and Africa Healthcare Nanotechnology Revenue (Million USD) by Countries (2015-2020)
Table 137. Middle East and Africa Healthcare Nanotechnology Revenue Market Share by Countries (2015-2020)
Table 138. Global Healthcare Nanotechnology Revenue (Million USD) by Type (2015-2020)
Table 139. Global Healthcare Nanotechnology Revenue Share by Type (2015-2020)
Table 140. Global Healthcare Nanotechnology Revenue Forecast by Type (2021-2025)
Table 141. Global Healthcare Nanotechnology Revenue by Application (2015-2020)
Table 142. Global Healthcare Nanotechnology Revenue Share by Application (2015-2020)
Table 143. Global Healthcare Nanotechnology Revenue Forecast by Application (2021-2025)
Table 144. Global Healthcare Nanotechnology Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Healthcare Nanotechnology Picture
Figure 2. Global Healthcare Nanotechnology Revenue Market Share by Type in 2019
Figure 3. Nanomedicine Picture
Figure 4. Nano Medical Devices Picture
Figure 5. Nano Diagnosis Picture
Figure 6. Others Picture
Figure 7. Healthcare Nanotechnology Revenue Market Share by Application in 2019
Figure 8. Anticancer Picture
Figure 9. CNS Product Picture
Figure 10. Anti-infective Picture
Figure 11. Others Picture
Figure 12. Global Healthcare Nanotechnology Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Healthcare Nanotechnology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Healthcare Nanotechnology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Healthcare Nanotechnology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Healthcare Nanotechnology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Healthcare Nanotechnology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Healthcare Nanotechnology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Healthcare Nanotechnology Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Healthcare Nanotechnology Revenue Market Share in 2019
Figure 21. Global Top 10 Players Healthcare Nanotechnology Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Healthcare Nanotechnology Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Healthcare Nanotechnology Revenue Market Share by Regions (2015-2020)
Figure 25. Global Healthcare Nanotechnology Revenue Market Share by Regions in 2018
Figure 26. North America Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 27. Europe Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 29. South America Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 31. North America Healthcare Nanotechnology Revenue Market Share by Countries (2015-2020)
Figure 32. North America Healthcare Nanotechnology Revenue Market Share by Countries in 2019
Figure 33. USA Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 34. Canada Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 36. Europe Healthcare Nanotechnology Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Healthcare Nanotechnology Revenue Market Share by Countries in 2019
Figure 38. Germany Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 39. UK Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 40. France Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 41. Russia Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 42. Italy Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Healthcare Nanotechnology Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Healthcare Nanotechnology Revenue Market Share by Countries in 2019
Figure 45. China Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 46. Japan Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 47. Korea Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 48. India Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 50. South America Healthcare Nanotechnology Revenue Market Share by Countries (2015-2020)
Figure 51. South America Healthcare Nanotechnology Revenue Market Share by Countries in 2019
Figure 52. Brazil Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Healthcare Nanotechnology Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Healthcare Nanotechnology Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 57. UAE Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Healthcare Nanotechnology Revenue and Growth Rate (2015-2020)
Figure 60. Global Healthcare Nanotechnology Revenue Share by Type (2015-2020)
Figure 61. Global Healthcare Nanotechnology Revenue Share by Type in 2019
Figure 62. Global Healthcare Nanotechnology Market Share Forecast by Type (2021-2025)
Figure 63. Global Nanomedicine Revenue Growth Rate (2015-2020)
Figure 64. Global Nano Medical Devices Revenue Growth Rate (2015-2020)
Figure 65. Global Nano Diagnosis Revenue Growth Rate (2015-2020)
Figure 66. Global Others Revenue Growth Rate (2015-2020)
Figure 67. Global Healthcare Nanotechnology Revenue Share by Application (2015-2020)
Figure 68. Global Healthcare Nanotechnology Revenue Share by Application in 2019
Figure 69. Global Healthcare Nanotechnology Market Share Forecast by Application (2021-2025)
Figure 70. Global Anticancer Revenue Growth Rate (2015-2020)
Figure 71. Global CNS Product Revenue Growth Rate (2015-2020)
Figure 72. Global Anti-infective Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Healthcare Nanotechnology Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Healthcare Nanotechnology Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Healthcare Nanotechnology Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Healthcare Nanotechnology Revenue Market Forecast (2021-2025)
Figure 78. Europe Healthcare Nanotechnology Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Healthcare Nanotechnology Revenue Market Forecast (2021-2025)
Figure 80. South America Healthcare Nanotechnology Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Healthcare Nanotechnology Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
医療用ナノテクノロジー（ナノメディシン）の世界市場（～2026年） It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular lev…- ナノテクノロジーの世界市場（～2026年） Nanotechnology applications are defined comprehensively as the creation and use of materials, devices and systems through the manipulation of matter at scales of less than 100 nanometers. Market Analysis and Insights: Global Nanotechnology Market The global Nanotechnology market size is projected to…
- ドラッグデリバリーにおけるナノテクノロジーの世界市場（～2026年） Drug Delivery Systems (DDS) refers to the different Delivery forms of various therapeutic drugs adopted by people in the process of disease prevention and treatment, which were called dosage forms in pharmacy before the 1960s. Rising demand from Asia-Pacific region a major driver for the growth of t…
- ナノテクノロジードラッグデリバリーの世界市場（～2026年） Nano-technology field has a potential to make significant impact on healthcare by delivering disease diagnosis, monitoring, implants, regenerative medicines and drug delivery, drug discovery for biomedicine. Since last few years, significant progress has been made in the field of nano-medicine (i.e.…
- 農業用ナノテクノロジーの世界市場（～2026年） Nanotechnology in agriculture is the application of extremely small tools such as sensors, which can be used for agricultural development. The global agricultural nanotechnology market is also segmented by end users which includes: farmers/producers, R&D institutes and government organizations. Mark…